Your SlideShare is downloading. ×
Sagacious research newsletter-28 oct-2013
Sagacious research newsletter-28 oct-2013
Sagacious research newsletter-28 oct-2013
Sagacious research newsletter-28 oct-2013
Sagacious research newsletter-28 oct-2013
Sagacious research newsletter-28 oct-2013
Sagacious research newsletter-28 oct-2013
Sagacious research newsletter-28 oct-2013
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Sagacious research newsletter-28 oct-2013

933

Published on

Sagacious Research is a fast growing Intellectual Property Research and Patent Search firm based in India providing global and multi-lingual Patent Searches and in-depth Licensing Support. …

Sagacious Research is a fast growing Intellectual Property Research and Patent Search firm based in India providing global and multi-lingual Patent Searches and in-depth Licensing Support.
At Sagacious, specialized & dedicated techno-legal patent search experts work with Patent Practitioners, Inventors/Researchers, In-house Patent Cousels/Businesses, and Technology Investors throughout the Patent Lifecycle helping take informed decisions.
Most important of our service offerings include global multi-lingual Prior-Art/ Patent Searches, Patent Licensing & Litigation Support, Patent Drafting Support, and Patent Watches/Monitoring.

Published in: Business
1 Comment
0 Likes
Statistics
Notes
  • Be the first to like this

No Downloads
Views
Total Views
933
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
6
Comments
1
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Follow Us at: Vol-8, Date: 28st October, 2013 SAGACI OUS UPDATES Sagacious Research Engages Mr. Dinesh Jain as Business Advisor Sagacious Research, a renowned name in the Patent Information community, has recently joined hands with Mr. Dinesh Jain, a seasoned and much experienced industry professional to scale new heights. Mr. Jain is now on-board of Sagacious Research as a Business Advisor. GENERAL NEWS Indian Patent office to Function as ISA & IPEA From 15th October 2013, Indian Patent office started functioning as the International Search Authority (ISA) and International Preliminary Examining Authority (IPEA) under PATENT COOPERATION TREATY (PCT). The International Searching Authorities and International Preliminary Examining Authorities are national Offices or inter-governmental organizations entrusted with a number of tasks under the PCT, especially the establishment of international search and preliminary examination reports. As an ISA & IPEA authority, Indian Patent Office can now search or examine a particular international application as per the agreement signed with International Authorities and the International Bureau. If another Authority is competent to perform the same search or examination of any particular application, the PCT applicant will choose the desired Authority in the request or demand. IPO will abide by PCT Regulations and Guidelines for execution of its new role and that will definitely make the search reports issued by Indian Patent office world-class. We Believe in Building Trust… © 2007 - 2013 Sagacious Research. All Rights Reserved. www.sagaciousresearch.com
  • 2. Purpose of International Preliminary Examination –  The purpose of international preliminary examination is not grant or refusal of a patent, but provision of a preliminary and nonbinding opinion on whether the claimed invention appears to be novel, to involve an inventive step and to be industrially applicable as defined in Article 33 PCT. It depends on the international application concerned and, especially, on the result of the international search.  It is carried out on condition that the applicant has (validly) filed a “demand” and paid the fees due and provides applicant with a good basis on which to evaluate the chances of obtaining patents before entering in national phases of various designated patent offices. Besides, this news is definitely a reason for delight for all Indian PCT applicants who can now select the Indian Patent Office as the ISA while filing a PCT application. This will reduce the Indian patent filing cost to ~50%. Earlier, PCT application fee was around 4000 US$ (when EP was chosen as ISA). Now, with IPO serving as ISA, PCT filing fees has come down to ~1800 US$ (which includes PCT filing fees along with 10,000 INR – Indian ISA fees). Our readers can get more insight into PCT International Search and Preliminary Examination Guidelines, http://www.wipo.int/export/sites/www/pct/en/texts/pdf/ispe.pdf S O M E O T H E R T O P N E W S I N T H I S C A T E G O R Y: European Patent Office Abolishes Prior “Short” Divisional Guidelines Read: http://goo.gl/5T7bUF Canada & European Union to Soon Enter in a Free Trade Agreement ‘CETA’ Read: http://goo.gl/YNAIZA Single Trans-Tasman Patent Application & Examination Processes for Patents Approved in New Zealand Read: http://goo.gl/YUYHTb US Congress Introduces Bill for Patent Law Reform in US Read: http://goo.gl/8dxrdl © 2007 - 2013 Sagacious Research. All Rights Reserved. www.sagaciousresearch.com
  • 3. LIFE SCIENCES Scaling Ahead of The Problem of Patent Cliff Patent Cliff refers to the phenomena of patent expiration dates and an abrupt drop in sales that follows for a group of products capturing high percentage of a market. An outbreak of patent expirations that started since 2010 is expected to continue till 2020. As such, majority of the multi-billion drug market would lose patent protection due to a phenomenon called as a ‘patent cliff’. Majority of the multi-billion drug market would lose patent protection due to a phenomenon called as a ‘patent cliff’. Patent Cliff refers to the phenomena of patent expiration dates and an abrupt drop in sales that follows for a group of products capturing high percentage of a market. Usually, this phenomena are noticed when they affect blockbuster drugs/pharmaceutical products, so called as their sale exceeds 1 billion USD per year. Some examples of blockbuster drugs discovered in the early 1990’s and going off patent between 2013 and 2015 are Cymbalta, Nexium, Clarinex, Celeberex and Abilify. Patent for others drugs like Rituxan, Humira, Novolog and Avastin are expiring by 2019. The abrupt drop in sales expected after the date of patent expiration can be estimated with a simple formula: Sales = A/Y Sales = A/Y Where, - “A” is the peak sales value before the patent expiration - “Y” the years after the peak sales year (where peak sales year is considered year 0) The drug industry has been cutting costs to help boost margins and compensate for those patent expirations. However, if we look at the larger picture, there are some positive facets of patent expirations that we often fail to even consider.  Rise of Generic Drug Makers & Lowering Down of Healthcare Cost Though the revenue obtained through the sales of these products is at risk of falling drastically within the years of the patent cliff but that will also open half of this market for aggressive generic majors. As such, companies like Sun Pharma, DRL, Lupin, Aurobindo, Alembic, Ranbaxy and others in India filed para-IV certifications to get FDA approval to sell their generic versions at an average of 30% of the price of the brand-name originals. Generics are already available for a number of drugs including Zyprexa.  Instigating Innovation & Business Growth Eli Lilly Co., a global pharma major, lost major patent protection on its all-time best-seller Zyprexa, an antipsychotic drug in 2011. This dropped its $4.6 billion sales in 2011 to cheaper-priced generics. In December, Lilly will also lose U.S. patent protection on its current No. 1 drug, the antidepressant Cymbalta, which generated $1.37 billion in sales in the last quarter. Yet, Eli Lilly is in the pursuit of launching of perhaps a half dozen new drugs by 2015 to offset much of the sales hit. Lilly has four new diabetes drugs scheduled to go on sale in 2014 and 2015, assuming they’re all approved by U.S. regulators. Ramucirumab, an experimental treatment for gastric cancer could soon reach the market too. The drug is in final-stage testing. Moreover, Lilly drastically expanded its business in China and in 2012 half of its revenue came from outside the U.S. © 2007 - 2013 Sagacious Research. All Rights Reserved. www.sagaciousresearch.com
  • 4. Way Forward – Biosimilars The biosimilar segment is fast growing (as per an estimate it will grow from $172 million in 2010 to an estimated $3.927 billion by 2017) and if biopharma companies take initiatives in this direction, they can greatly benefit and boost their sales and growth despite of patent cliff besides compensating for huge losses incurred upon them due to patent expirations of blockbuster biologic compounds by 2020 that generated a combined sale of $67 billion for them. Biosimilars are officially approved subsequent versions of a biological medicine that has already been patented or authorized and are made by a different sponsor following patent and exclusivity expiry. In US, FDA and in Europe, European Medicines Agency (EMA) regulates the approval procedure for biosimilars. Conclusion So basically, patent cliff isn’t that big an issue that it is perceived as. It is just a transitory phase in the global business climate wherein the financial future of pharmaceutical companies will depend on how they manage the transition of many of their brand drugs to the generic market and on their ability to develop novel therapeutics with significant profit potential and finding alternatives like biosimilars. S O M E O T H E R T O P N E W S I N T H I S C A T E G O R Y: The 3 Best-Selling Drugs in the World: Read: http://goo.gl/wRH3aQ Myriad Sues GeneDx on BRCA & Other Genetic Diagnostic Patents Read: http://goo.gl/7Ywnml Are Patents Blocking Access to Life-Saving Drugs in India? Read: http://bit.ly/HcKID1 Eli Lilly’s Profit Soars as US Patents on Anti-depressent Drug “Cymbalta” Nears Expiration Read: http://goo.gl/KVMifb TECHNOLOGY Smartphone War- Nokia vs. Blackberry Nokia Corporation has sued Blackberry for infringing its “WLAN patents” One of the most prolific patent war happened between Nokia and Blackberry in 2012. Finnish mobile giant accused Research in Motion for infringing WLAN patents that enable the handsets to connect to wireless local access network or WiFi. Wi-Fi allows cheaper deployment of local area networks (LANs) and thus, manufacturers are building WLAN or wireless network adapters into most of the devices including laptops and mobiles. If a smartphone is capable of using built-in Wi-Fi, it gives its users the opportunity to connect easily from hotels, home, offices, book stores and client sites. WLAN boosts business efficiency as research, invoicing, email and project development can be handled without having to return to a desktop computer at the main office. © 2007 - 2013 Sagacious Research. All Rights Reserved. www.sagaciousresearch.com
  • 5. In 2012, a smartphone war broke out in German, UK and US courtrooms between smartphone manufacturing giants costing billions of dollars to fighting companies. Nokia accused Blackberry manufacturer of infringing WLAN patents that enable the handsets to connect to wireless local access network or WiFi. The company had earlier lost a patent dispute to Nokia for infringing WLAN patents and agreed to pay them a hefty royalty. But the two companies could not negotiate and agree on license fees. RIM, then mistakenly thought it would benefit from triggering an arbitration proceeding, which it initiated in April 2011. This backfired. Then, Nokia, who settled its infringement lawsuits on reasonable licensing fees with other companies like Apple, became hell bent on seeking the ban of Blackberry devices in US, UK and Canada. Later in December, two companies could reach to an agreement but its terms were not disclosed. The two mobile companies were also battling in German courts in a separate patent infringement case dealing with media tags, software update methods and data sharing. About WLAN Technology Wi-Fi allows cheaper deployment of local area networks (LANs) and thus, manufacturers are building WLAN or wireless network adapters into most of the devices including laptops and mobiles. If a smartphone is capable of using built-in Wi-Fi, it gives its users the opportunity to connect easily from hotels, home, offices, book stores and client sites. It boosts business efficiency as research, invoicing, email and project development can be handled without having to return to a desktop computer at the main office. As such, use of WiFi equipped devices like laptops and mobile phones helps tremendously in day-to-day activities. Here are two exemplary patents that were granted to Nokia Corporation in WLAN technology area1. US 8363626 B2 – Patent on Mechanism to enable discovery of link/network features in WLAN networks 2. WO 2004034714 A8- Patent on Network selection in a WLAN In general, patents are open to interpretation but if the company owing those patents believes that its rival has copied its patent without paying royalties for it, then it can attempt to sue for patent infringement. If successful, the firm found guilty of infringing may be ordered to pay damages and royalties for the use of the patent. In extreme cases, it can also request a ban on those patents. It is illegal if standard essential patents (or SEP’s) are used without entering in a licensing deal with the inventor on fair, reasonable and non-discriminatory (FRAND) terms. As far as Nokia’s WLAN patents are concerned, they are required by every phone to work and thus, these are standard essential patents. Nokia sued Blackberry for patent infringement as it found that their mobile phones were using this technology without paying royalties for it. When Nokia could not be satisfied with the terms of licensing, it requested a ban on the sale of the infringing products. Here, it is also important to note that the patent portfolio of Nokia is quite strong. Nokia has aggressively defended its patent portfolio while its handset business has fallen on tough times. Recently, it hitched its smartphone wagon to Microsoft’s Windows Phone platform in a bid to recapture some of market lost to Apple and Google’s Android-based mobile offerings. But it continues to generate around £400m of revenue from patent royalties each year and thus, company’s royalty payments are of special interest. Like Nokia, RIM has been losing market share since the introduction of the iPhone and Android devices and the company is struggling to reverse the current trend but has failed to do that so far. The poor sales performance of the BlackBerry Z10 embedded with new Blackberry 10 operating software was also a major blow to the corporation’s fortunes. One of the strongest drawbacks of Blackberry has been the lack of foresight in matters related to securing rights over some essential technologies. While Nokia proactively secured their patent rights in a timely manner over some really important technologies (like WLAN) and managed to reap good profits from their patent portfolio, Blackberry who also owes a patent portfolio worth millions of dollars, failed to do so. If the company would have managed its patents strategically, which it could have done by investing its resources as in technology watch services that help in keeping track of all the technologies that may be patented in this domain, it could have averted such unfortunate losses on litigation matters related to intellectual property. © 2007 - 2013 Sagacious Research. All Rights Reserved. www.sagaciousresearch.com
  • 6. An insightful patent search report produced by a professional patent search service provider is an effective tool against infringement lawsuits that incurs losses of millions of dollars to the technology firms, such as Blackberry. It is time that Blackberry, regardless of the path that it choose to follow, understand that the company’s patent portfolio is its primary asset and it needs to be managed in a professional manner. Why is Blackberry Accruing Patents? BlackBerry Ltd.’s sales are tumbling and yet the ace smartphone maker is actively accruing patents. BB- Patent Portfolio Overview BlackBerry currently holds 5,236 U.S. patents and approximately 3,730 active patent applications. According to an estimate given by Intellectual Property Owners Association, the company received 986 patents last year, a 49% increase from 2011. As such; it is much evident that Blackberry is hoarding intellectual-property. The struggling smartphone maker is exploring new strategic options including a sale, and the buzz is that if that happens, BlackBerry’s patents will certainly make it a fairly valuable and lucrative buy. BB- Patent Age Blackberry’s patent portfolio’s average patent age is just 3.4 years. Patents last 20 years from the date of their application, making BlackBerry’s 3.4-year average appealing. In the typical portfolio, just about 5 percent of patents have any real value because not all patents are created equal. Yet, a 15-plus year of useful life of Blackberry’s portfolio, makes it quite significant. An Insight into a Few Important Patents of BB BB Patents for QNX technology QNX technology, also used in BlackBerry 10 operating system, is a platform for devices that manage nuclear-power plants, car infotainment systems and unmanned aerial drones for the U.S. military. Premium companies, including Porsche, Cisco, General Electric Co. and Caterpillar Inc., are using this technology in their products. BB-Patents for Information Security Besides that, BlackBerry has 9,268 granted patents and applications including 190 patents related to information security, which remains the core of its appeal to government, bank and military customers like the North Atlantic Treaty Organization. For example, U.S. Patent 20130254528 entitled Secure Message Handling on a Mobile Device that maintains efficiency in power use for sending and forwarding e-mails while improving digital security. Typically, an e-mail message forwarded from a mobile device doesn’t include an encrypted signature when directing the e-mail to a messaging server, but this innovation would include the encryption without increasing bandwidth use. BB-Patents for Qwerty Keyboards BlackBerry is still active in claiming patent rights for devices with full keyboards. Likewise, with U.S. Patent 8537108 entitled Navigation Tool with Audible Feedback on a Handheld Communication Device Having a Full Alphabetic Keyboard, the company has developed a better system for providing user feedback of device navigation through a keyboard input. Here, a navigation tool on the keyboard © 2007 - 2013 Sagacious Research. All Rights Reserved. www.sagaciousresearch.com
  • 7. would provide an audible sound when operated by a user to navigate between icons and other selectable items. In another patent filing, company reveals a Storable Keyboard having variable angular orientations. A keyboard moves between a stored position inside the housing and a deployed position just like a matchbox. A few outstanding patent buy outs and deals that have been signed: 1. In the Nortel auction of July 2011, more than 6,000 patents from Nortel were auctioned for approx. $4.5 billion and BlackBerry paid about $770 million for its share. Other potential bidders were Apple Inc., Google, Nokia etc. 2. Google paid $12.5 billion for Motorola Mobility, another former mobile-phone pioneer, primarily for a patent portfolio so that it could use it as a safeguard against litigation involving its Android operating system. 3. Most recent Nokia Microsoft $7.2 billion deal shows that patents still have plenty of value, including their ability to create fresh revenue. Nokia sold its handset business to Microsoft but kept control of its patents, which now generate more than 500 million euros ($676 million) a year in licensing revenue. It is much evident that BlackBerry has a rich patent portfolio. Thus, BlackBerry could drive its bidding price to as much as $5 billion. Financial Holdings Ltd. has already offered a $4.7 billion buyout proposal to Blackberry but no official deal has been signed. Negotiations with relevant bidders play a vital role in such a scenario, thus, seeking services from patent research service providers who provide product-to-patent mapping services is a much thought over and calculated step. These services can help potential buyers (and/or sellers) in evaluating and understanding what patented technology is behind the product and what all features of a product can be attributed to its patent. Thus, strategic business decisions regarding segregating patent portfolio into patents with potential for buying/selling and licensing can be formulated. Conclusion It is unlikely that Blackberry commands the same premium as Nortel or Motorola Mobility because market has changed. But it is certain that if BlackBerry’s portfolio is properly analysed, it can make the company a very lucrative buy. Its licensable patents alone should be able to earn on an average at least $100 million in licensing revenue annually. S O M E O T H E R T O P N E W S I N T H I S C A T E G O R Y: AMD, Altera, ADI Emerges Top 3 semiconductor Innovators: Says Patent Metric Read: http://goo.gl/Hc8Tva Twitter’s Dearth of Patents Could Hinder it Down the Road: Says Report Read: http://goo.gl/4v2eB8 ‘Steve Jobs Patent’ On Multitouch To Blow Off All Android Makers as USPTO Confirms All Its 20 Claims Read: http://goo.gl/YDdAfL Google Plans to Patent DJ’s Favorite Hand Gestures Read: http://goo.gl/dL6Yxu Neonode Wins US Patent for Flush (Bezel-free) Cover-Glass Design, With Potential to Replace Capacitive Touchscreens Read: http://goo.gl/pRrzsm © 2007 - 2013 Sagacious Research. All Rights Reserved. www.sagaciousresearch.com
  • 8. AB O UT SAGAC I O U S R E S EAR C H Sagacious Research is an ISO Certified India based Global Patent Research & Analytics firm offering cost effective & multi-lingual Patent Searching, Patent Licensing, Patent Alerts & Watches, Patent Drafting, Trademark Searching & Design Searching Services in over 100 countries and in over 16 Asian/European languages. An ISO 9001:2008 and ISO 27001:2005 Certified Company 70+ Techno-legal Experts | 16+ Languages | 100 Countries | 5, 000+ Projects | 99% Client Retention C O NTAC T SAGAC I O U S R E S EAR C H Germany United States Kathrin Reinhardt +49 6107 6383 396 6387 Fairways Drive Longmont, CO-80503 T: (303) 506-4192 F: (803) 831-1899 United Kingdom Aarti Thakral +44 (0) 203287 5098 India (HQ) United States 303-B, Enkay Town Plaza, Block-I, Palam Vihar, Gurgaon-122017, Delhi/NCR, India T: +91 124 4033431 F: +91 11 43850700 Jim Worrell +1 803 526 7267 Australia Web: Steve Johnson +61 3 9028 4017 info@sagaciousresearch.com www.sagaciousresearch.com SAGAC IO U S R E S EAR C H S E RVI C E S Litigation / Licensing Support Services Prosecution/ Strategy Support Services Paralegal Support Other Services Global Trademark Searches I n v a l i d i t y/ Opposition Searches Infringer Identificatio n Patentability / Novelty Searches Patent Landscape Studies Patent Proofreading Patents Mining Claim/EoU Charting FTO/ Clearance Searches Competition/ Technology Watches IDS Preparation Patent Illustrations/ Drawings Structure/ Sequence Searches Patent Docketing Claim Construction Reverse Engineering Patent Translations © 2007 - 2013 Sagacious Research. All Rights Reserved. www.sagaciousresearch.com Design Searches Prosecution Watch

×